Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

186.27
-3.6100-1.90%
Volume:1.04M
Turnover:194.61M
Market Cap:329.03B
PE:79.61
High:190.67
Open:190.22
Low:186.21
Close:189.88
Loading ...

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Alkermes (ALKS)

TIPRANKS
·
7 hours ago

AbbVie’s Innovative Approach to Crohn’s Disease: A Study Update

TIPRANKS
·
22 hours ago

AbbVie’s SWITCH-UP Study: A New Hope for Atopic Dermatitis Treatment?

TIPRANKS
·
22 hours ago

AbbVie’s Phase 3 Study on Upadacitinib for SLE: Key Insights for Investors

TIPRANKS
·
22 hours ago

AbbVie’s ABBV-101 Study: A New Hope for B-Cell Malignancies?

TIPRANKS
·
22 hours ago

AbbVie’s CLL Study: A Potential Game-Changer in Cancer Treatment?

TIPRANKS
·
22 hours ago

Abbvie and Genmab’s Promising Study on Epcoritamab for Lymphoma: A Financial Perspective

TIPRANKS
·
22 hours ago

AbbVie Inc. Files Initial Statement of Beneficial Ownership by EVP and Chief HR Officer Demetris D. Crum

Reuters
·
12 Jul

AbbVie Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
12 Jul

INDIA STOCKS-India's equity benchmarks log weekly losses as IT stocks drag

Reuters
·
11 Jul

Glenmark Pharma Shares up 10% in Pre-Open Trade After Unit, Abbvie Ink Licensing Deal

THOMSON REUTERS
·
11 Jul

AbbVie (ABBV) Laps the Stock Market: Here's Why

Zacks
·
11 Jul

AbbVie Inc. (ABBV): A Bull Case Theory

Insider Monkey
·
11 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AbbVie, McDonald's

Reuters
·
11 Jul

AbbVie and Genmab’s Epcoritamab Trial: A Promising Update for B-NHL Treatment

TIPRANKS
·
11 Jul

BUZZ-AbbVie rises after licensing deal for cancer treatment with India's Glenmark Pharma unit

Reuters
·
10 Jul

Abbvie Shares up 2.3% After Licensing Deal for Cancer Treatment With India's Glenmark Pharma Unit

THOMSON REUTERS
·
10 Jul

Ichnos Glenmark Innovation (Igi) and Abbvie Announce Exclusive Global Licensing Agreement for Isb 2001, a First-in-Class Cd38×Bcma×Cd3 Trispecific Antibody

THOMSON REUTERS
·
10 Jul

Abbvie Inc - Igi to Receive $700 Mln Upfront and $1.225 Bln in Milestones

THOMSON REUTERS
·
10 Jul

AbbVie (ABBV) Receives a Buy from Morgan Stanley

TIPRANKS
·
10 Jul